BiotechTube
Home/Vaxart/Jeroen Grasman
JG

Jeroen Grasman

Chief Financial Officer

Vaxart

Therapeutic Areas

Infectious DiseasesGastroenterology

Vaxart Pipeline

DrugIndicationPhase
Oral Norovirus VaccineNorovirus GastroenteritisPhase 2
Oral COVID-19 VaccineCOVID-19Phase 2
Oral Influenza VaccineSeasonal InfluenzaPhase 2
Oral RSV VaccineRespiratory Syncytial Virus (RSV)Preclinical/Phase 1

Leadership Team at Vaxart

SL
Steven Lo
Chief Executive Officer
ST
Sean Tucker, Ph.D.
Founder, Senior Vice President and Chief Scientific Officer
JF
James F. Cummings, M.D.
Chief Medical Officer
View full Vaxart profile